220 likes | 248 Views
This study examines the experience of implementing rapid HIV tests in eleven African countries to meet the goals of the Emergency Plan. It includes evaluations, testing strategies, and implementation phases to ensure quality and access to HIV testing.
E N D
Evaluation and implementation of rapid HIV tests: the experience in eleven African countries Dr. Stefan Wiktor Chief, Surveillance and Infrastructure Development Branch Global AIDS Program CDC/HHS
Adults and children estimated to be living with HIV/AIDS - 2004 Eastern Europe & Central Asia 1.2 – 1.8 million Western Europe 520 000 – 680 000 North America 790 000 – 1.2 million East Asia & Pacific 700 000 – 1.3 million North Africa & Middle East 470 000 – 730 000 South & South-East Asia 4.6 – 8.2 million Caribbean 350 000 – 590 000 Sub-Saharan Africa 25.0 – 28.2 million Latin America 1.3 – 1.9 million Australia & New Zealand 12 000 – 18 000 Total: 34 – 46 million
President’s Emergency Plan for AIDS Relief • Announced January 28, 2003 • 15 focus countries • Goals: • Prevent 7 million new HIV infections • Treat 2 million HIV-infected people • Provide care for 10 million HIV-infected people and AIDS orphans • Overall budget for global AIDS: $15 billion over 5 years ($10 billion new money, including $1billion for Global Fund)
President’s Emergency Plan for AIDS Relief15 Focus Countries Ethiopia Uganda Haiti Kenya Guyana Rwanda Côte d’Ivoire Tanzania Nigeria Zambia Vietnam added 7/04 Namibia Mozambique Botswana South Africa
The role of HIV testing to meet the goals of the Emergency Plan • Massive scale-up of testing capacity needed: 30-100 million persons tested • Broad range of testing sites with personnel of varying levels of training/experience • Lack of infrastructure or environment for quality assurance • CDC-GAP focus on expanding access to HIV testing with focus on rapid tests
Emergency Plan strategy to improve access and quality of rapid HIV testing • Facilitate procurement • Develop guidelines • Strengthen/develop national reference laboratory • Advocacy • Renovations, equipment • Technical assistance • External quality assurance • Provide training – WHO/CDC rapid HIV test curriculum
HIV testing is expanding rapidly(Number of HIV tests performed in CDC/GAP supported programs)
HIV testing is expanding rapidly(Number of CDC/GAP supported sites qualified to perform HIV testing)
WHO-AFRO/HHS- CDC/APHL Guidelines For Appropriate Evaluations of HIV Testing Technologies in Africa
Steps to in-country rapid HIV test evaluation and implementation Serum panel: Collect, characterize, store National Reference Lab Phase I Evaluate tests, select 2-or-3 test algorithm Pilot testing algorithm in testing sites Point-of- service site Phase II EQA and ongoing monitoring of testing National Reference Lab/ Point of service site Phase III
Ethiopia Uganda Kenya Senegal Rwanda Côte d’Ivoire Tanzania Angola Namibia Mozambique Botswana Evaluation and implementation of rapid HIV tests in 11 African countries • Country contacts identified – working group created • Questionnaire administered concerning evaluations: • Process • Results • Implementation
Determine Delta HIV ½ Doublecheck Genie II Hema-Strip Hexagon HIV Spot ImmunComb Instant CHEK InstantScreen Rapid MultiSpot Oraquick Sero-Strip Swift Stat-Pak UniGold Virocheck Rapid HIV tests evaluated
Phase I evaluations • Conducted in national reference or hospital laboratories • Serum panels created: • Median 506 samples (range 51-2000) • Median HIV prevalence 38% (range 14-78%) • Median duration 6 months (range 2-26 months) • Results: • Median sensitivity >99% for 12 tests • Median specificity >99% for 14 tests
Median sensitivity of rapid HIV tests in evaluations conducted in central reference laboratories in 11 African countries # of evals: 11 11 10 10 6 3 3 2 2
Median specificity of rapid HIV tests in evaluations conducted in central reference laboratories in 11 African countries # of evals: 11 11 10 10 6 3 3 2 2
Phase II evaluations • Conducted in variety of settings (VCT, blood donation centers, hospitals) • Whole-blood samples; on-site testing with repeat testing at reference laboratory • Median 566 samples (range 209-3,791) • Results comparable to Phase I evaluations
Phase III: status of rapid HIV test implementation • National algorithm selected in 10 countries: • Serial algorithm - 6 countries • Parallel algorithm - 4 countries • Screening: Determine and Unigold – 7 countries • Tie-breaker or retesting • External quality assurance – 6 countries • Site visits • Retesting of specimens at reference laboratory • External proficiency testing (Zimbabwe)
External quality assurance: comparison of results of on-site rapid HIV testing with central laboratory EIA/WB testing
Conclusions • Testing needs are huge • HIV testing is scaling up rapidly • HIV rapid tests work • Testing is conducted in variety of sites by persons with varying levels of experience • Quality assurance: a major and growing challenge
Acknowledgements:Rapid HIV Test Evaluation Working Group Co-ordinating group K. Bond, B. Branson, P. Crippen, A. Demby, T. Diaz, M. Downer, G. Gershy-Damet , T. Granade, T. Hearn, K. Lewis, T. Merlin, D. Plate M. Rayfield, R. Respess J. Ridderhof A. Tanuri, S. Wiktor In-country Collaborators Angola: C. Fernandes, F. da Silva, M. Francisco, F. del Castillo, J. Cox Botswana: T. Roels, L. Povinelli, P. Kilmarx Ethiopia: B. Tegbaru, A. Geyed, M. Fekadu, J. Mengistu, T. Wuhib Ivory Coast: C. Maurice, A. Tehe, D. Yavo Kenya: J. Nyamongo, N. Achola, K. Mandaliya, P. Tukei, L. Marum, K. DeCock Mozambique:A. Barreto, S. Stakteas, K. Marsh, A. Vergara Namibia: C. Weiss, H. Kaura, T. Kenyon Rwanda: P. Rugimbanya, E. Rusanganwa, J. Hanson, V. Koscelnik Senegal: M. Gueye, S. Mboup, C. Murrill Tanzania: E. Lyamuya, Y. Ipuge, C. Kagoma, C. Scott Zimbabwe: J. Mudzori, Z. Ziyambi, K. Mutasa, E. Burke, M. St. Louis